Zobrazeno 1 - 6
of 6
pro vyhledávání: '"L. Tilova"'
Autor:
E. Lesovaya, L. Tilova, O. Zadorozhnaya, A. Savinkova, K. Kirsanov, A. Ogloblina, G. Belitsky, G. Baida, I. Budunova, M. Yakubovskaya
Publikováno v:
EJC Supplements, Vol 13, Iss 1, Pp 33-34 (2015)
Glucocorticoids (GCs) are widely used in treatment of many cancer types due to its ability to induce apoptosis in malignant cells in blood cancer therapy, and to prevent nausea, emesis and chemotherapy-associated hepatotoxicity in case of solid tumor
Externí odkaz:
https://doaj.org/article/6c192e706feb4d07833fffde38317c74
Autor:
L. Tilova, O. Zadorozhnaya, A. Savinkova, K. Kirsanov, A. Ogloblina, G. Belitsky, I. Budunova, E. Lesovaya, M. Yakubovskaya
Publikováno v:
EJC Supplements, Vol 13, Iss 1, Pp 61-62 (2015)
Glucocorticoids (GCs) are the most important component of therapy for a number of diseases including combined chemotherapy of hematological malignancies. However, their application is strongly restricted by the development of serious side effects as
Externí odkaz:
https://doaj.org/article/c380fd2fa834413980e81c5f6c9005f7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
K. Kirsanov, A. Savinkova, V. Shirinyan, E. Zhidkova, L. Tilova, Marianna G. Yakubovskaya, E. Lesovaya, T. I. Fetisov, K. Kuzin
Publikováno v:
ESMO Open. 3:A122
Introduction Glucocorticoids (GCs) are widely used in blood cancer treatment; although, they cause metabolic disorders. Biological response to GCs is mediated by glucocorticoid receptor (GR) regulating gene expression via transactivation (TA), which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39e6021a8547901d8ea3e864000785b5
https://doi.org/10.1136/esmoopen-2018-eacr25.292
https://doi.org/10.1136/esmoopen-2018-eacr25.292
Autor:
A. Savinkova, K. Kirsanov, E. Lesovaya, G. Belitsky, O. Zadorozhnaya, Irina Budunova, L. Tilova, A. Ogloblina, Marianna G. Yakubovskaya
Publikováno v:
EJC Supplements, Vol 13, Iss 1, Pp 61-62 (2015)
Glucocorticoids (GCs) are the most important component of therapy for a number of diseases including combined chemotherapy of hematological malignancies. However, their application is strongly restricted by the development of serious side effects as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::901b6c5fc9b896a04bdf7de458a0e0df
Autor:
O. Zadorozhnaya, Marianna G. Yakubovskaya, Irina Budunova, A. Savinkova, G. Belitsky, L. Tilova, A. Ogloblina, K. Kirsanov, E. Lesovaya, Gleb Baida
Publikováno v:
EJC Supplements, Vol 13, Iss 1, Pp 33-34 (2015)
Glucocorticoids (GCs) are widely used in treatment of many cancer types due to its ability to induce apoptosis in malignant cells in blood cancer therapy, and to prevent nausea, emesis and chemotherapy-associated hepatotoxicity in case of solid tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3169d9c11e88935c075d04eb539d4e70